Old Web
English
Sign In
Acemap
>
authorDetail
>
Stan Kolis
Stan Kolis
Hoffmann-La Roche
Growth inhibition
In vivo
Oral administration
Endocrinology
Internal medicine
3
Papers
60
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Biological evaluation of a multi-targeted small molecule inhibitor of tumor-induced angiogenesis.
2006
Bioorganic & Medicinal Chemistry Letters
Lee Apostle Mcdermott
Brian Higgins
Mary Simcox
Kin-Chun Luk
Tom Nevins
Kenneth Kolinsky
Melissa Smith
Hong Yang
Jia K. Li
Yingsi Chen
June Ke
Navita L. Mallalieu
Tom Egan
Stan Kolis
Aruna Railkar
Louise Gerber
Jin-Jun Liu
Fred Konzelmann
Zhuming Zhang
Tom Flynn
Omar Jose Morales
Yi Chen
Show All
Source
Cite
Save
Citations (9)
RO4383596, an orally active KDR, FGFR, and PDGFR inhibitor : Synthesis and biological evaluation
2005
Bioorganic & Medicinal Chemistry
Lee Apostle Mcdermott
Mary Simcox
Brian Higgins
Tom Nevins
Kenneth Kolinsky
Melissa Smith
Hong Yang
Jia K. Li
Yingsi Chen
June Ke
Navita L. Mallalieu
Tom Egan
Stan Kolis
Aruna Railkar
Louise Gerber
Kin-Chun Luk
Show All
Source
Cite
Save
Citations (21)
Antitumor efficacy of AG3340 associated with maintenance of minimum effective plasma concentrations and not total daily dose, exposure or peak plasma concentrations
1998
Investigational New Drugs
David R. Shalinsky
John Brekken
Helen Y. Zou
Stan Kolis
Alexander W. Wood
Stephanie Webber
Krzysztof Appelt
Show All
Source
Cite
Save
Citations (30)
1